Target intelligence / Profile preview

Ribosomal protein L31 pseudogene 61 (RPL31P61)

Target: RPL31P61
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein L31 pseudogene 61 (RPL31P61) is one of many processed pseudogenes in the human genome that are derived from the RPL31 gene, which encodes a component of the large 60S ribosomal subunit[7][3][5]. Pseudogenes such as RPL31P61 do not produce functional proteins and are not involved in canonical biological pathways or considered for therapeutic targeting. The functional RPL31 gene is a structural constituent of the ribosome, but RPL31P61 itself does not encode protein or participate in protein synthesis[7][2][5]. Thus, it should not be treated as an active drug target.

Other names: RPL31_34_1652RPL31P61[7]

Beyond the preview

Go deeper on Ribosomal protein L31 pseudogene 61 (RPL31P61).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L31 pseudogene 61 (RPL31P61).

Explore the full profile